The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Mechanisms of PTEN loss in cancer: It’s all about diversity
Open accessAbstract
PTEN is a phosphatase which metabolises PIP3, the lipid product of PI 3-Kinase, directly opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly, loss of function of the PTEN tumour suppressor is one of the most common events observed in many types of cancer. Although the mechanisms by which PTEN function is disrupted are diverse, the most frequently observed events are deletion of a single gene copy of PTEN and gene silencing, usually observed in tumours with little or no PTEN protein detectable by immunohistochemistry. Accordingly, with the exceptions of glioblastoma and endometrial cancer, mutations of the PTEN coding sequence are uncommon (<10%) in most types of cancer. Here we review the data relating to PTEN loss in seven common tumour types and discuss mechanisms of PTEN regulation, some of which appear to contribute to reduced PTEN protein levels in cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedRen, P., Gong, F., Zhang, Y., Jiang, J., & Zhang, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4150-3 · Cited by 78
RetractedLi, H., Zhang, P., Sun, X., Sun, Y., Shi, C., Liu, H., & Liu, X. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3144 · Cited by 58
RetractedBi, M., Chen, W., Yu, H., Wang, J., Ding, F., Tang, D. J., & Tang, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.055 · Cited by 23
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
MicroRNA Signatures in Human Ovarian Cancer
Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.-G., Alder, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1936 · Cited by 1,394
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,320
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J. M., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,228
Reversible Inactivation of the Tumor Suppressor PTEN by H2O2
Lee, S.-R., Yang, K.-S., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111899200 · Cited by 1,057
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S. M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.029 · Cited by 1,019
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
PI3K signalling: the path to discovery and understanding
Vanhaesebroeck, B., Stephens, L., & Hawkins, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3290 · Cited by 987
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Lee, Y.-R., Chen, M., & Pandolfi, P. P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0015-0 · Cited by 917
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Wang, E.-Y., & Li, S.-Y. (1990) · Cited by 884
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Palomero, T., Sulis, M. L., Cortina, M., Real, P. J., Barnes, K., Ciofani, M., Caparros, E., Buteau, J., Brown, K., Perkins, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1636 · Cited by 877
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function
Vazquez, F., Ramaswamy, S., Nakamura, N., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5010-5018.2000 · Cited by 774
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
MicroRNA Expression Profiles in Serous Ovarian Carcinoma
Nam, E. J., Yoon, H., Kim, S. W., Kim, H., Kim, Y. T., Kim, J. H., Kim, J. W., & Kim, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1731 · Cited by 740
Bufill, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-10-779 · Cited by 722
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
Wang, X., Trotman, L. C., Koppie, T., Alimonti, A., Chen, Z., Gao, Z., Wang, J., Erdjument-Bromage, H., Tempst, P., Cordon-Cardo, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.039 · Cited by 720
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Ambs, S., Prueitt, R. L., Yi, M., Hudson, R. S., Howe, T. M., Petrocca, F., Wallace, T. A., Liu, C.-G., Volinia, S., Calin, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0144 · Cited by 704
PTEN: Life as a Tumor Suppressor
Simpson, L., & Parsons, R. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5130 · Cited by 679
Pten Dose Dictates Cancer Progression in the Prostate
Trotman, L. C., Niki, M., Dotan, Z. A., Koutcher, J. A., Di Cristofano, A., Xiao, A., Khoo, A. S., Roy-Burman, P., Greenberg, N. M., Dyke, T. V., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000059 · Cited by 676
Clinical implications of PTEN loss in prostate cancer
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., De Marzo, A. M., Squire, J. A., & Lotan, T. L. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.9 · Cited by 651
Kwon, J., Lee, S.-R., Yang, K.-S., Ahn, Y., Kim, Y. J., Stadtman, E. R., & Rhee, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407396101 · Cited by 631
The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus
Torres, J., & Pulido, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009134200 · Cited by 629
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
Leslie, N. R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg513 · Cited by 616
Self-citationFrequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Lui, V. W. Y., Hedberg, M. L., Li, H., Vangara, B. S., Pendleton, K., Zeng, Y., Lu, Y., Zhang, Q., Du, Y., Gilbert, B. R., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0103 · Cited by 589
Subtle variations in Pten dose determine cancer susceptibility
Alimonti, A., Carracedo, A., Clohessy, J. G., Trotman, L. C., Nardella, C., Egia, A., Salmena, L., Sampieri, K., Haveman, W. J., Brogi, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.556 · Cited by 580
Zhang, J.-G., Wang, J.-J., Zhao, F., Liu, Q., Jiang, K., & Yang, G.-H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.074 · Cited by 563
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
Worby, C. A., & Dixon, J. E. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-082411-113907 · Cited by 535
Oncogenic PI3K and its role in cancer
Samuels, Y., & Ericson, K. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198021.99347.b9 · Cited by 521
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Ding, Z., Wu, C.-J., Chu, G. C., Xiao, Y., Ho, D., Zhang, J., Perry, S. R., Labrot, E. S., Wu, X., Lis, R., et al. (2011) · Nature · doi:10.1038/nature09677 · Cited by 515
PTEN function: how normal cells control it and tumour cells lose it
LESLIE, N. R., & DOWNES, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 451
Self-citationmiR-21 as a key regulator of oncogenic processes
Selcuklu, S. D., Donoghue, M. T. A., & Spillane, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370918 · Cited by 445
Silva, A., Yunes, J. A., Cardoso, B. A., Martins, L. R., Jotta, P. Y., Abecasis, M., Nowill, A. E., Leslie, N. R., Cardoso, A. A., & Barata, J. T. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34616 · Cited by 443
Self-citationVazquez, F., Grossman, S. R., Takahashi, Y., Rokas, M. V., Nakamura, N., & Sellers, W. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100556200 · Cited by 413
Poliseno, L., Salmena, L., Riccardi, L., Fornari, A., Song, M. S., Hobbs, R. M., Sportoletti, P., Varmeh, S., Egia, A., Fedele, G., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000594 · Cited by 410
Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress
Bassi, C., Ho, J., Srikumar, T., Dowling, R. J. O., Gorrini, C., Miller, S. J., Mak, T. W., Neel, B. G., Raught, B., & Stambolic, V. (2013) · Science · doi:10.1126/science.1236188 · Cited by 403
Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M. B., Yuan, X.-J., Wood, J., Ross, C., Sawyers, C. L., & Whang, Y. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4233 · Cited by 400
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
Virolle, T., Adamson, E. D., Baron, V., Birle, D., Mercola, D., Mustelin, T., & de Belle, I. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1124 · Cited by 399
Song, L.-B., Li, J., Liao, W.-T., Feng, Y., Yu, C.-P., Hu, L.-J., Kong, Q.-L., Xu, L.-H., Zhang, X., Liu, W.-L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39374 · Cited by 398
Perren, A., Weng, L.-P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L. M., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65227-3 · Cited by 378
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
Lotan, T. L., Gurel, B., Sutcliffe, S., Esopi, D., Liu, W., Xu, J., Hicks, J. L., Park, B. H., Humphreys, E., Partin, A. W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1244 · Cited by 348
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Cao, J., Schulte, J., Knight, A., Leslie, N. R., Zagozdzon, A., Bronson, R., Manevich, Y., Beeson, C., & Neumann, C. A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.101 · Cited by 344
Self-citationMutations of the human PTEN gene
Bonneau, D., & Longy, M. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<109::aid-humu3>3.0.co;2-0 · Cited by 333
Gimm, O., Perren, A., Weng, L.-P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65040-7 · Cited by 327
Krohn, A., Diedler, T., Burkhardt, L., Mayer, P.-S., De Silva, C., Meyer-Kornblum, M., Kötschau, D., Tennstedt, P., Huang, J., Gerhäuser, C., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.04.026 · Cited by 324
A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival
Hopkins, B. D., Fine, B., Steinbach, N., Dendy, M., Rapp, Z., Shaw, J., Pappas, K., Yu, J. S., Hodakoski, C., Mense, S., et al. (2013) · Science · doi:10.1126/science.1234907 · Cited by 320
Loree, J. M., Pereira, A. A. L., Lam, M., Willauer, A. N., Raghav, K., Dasari, A., Morris, V. K., Advani, S., Menter, D. G., Eng, C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2484 · Cited by 316
Haddadi, N., Lin, Y., Travis, G., Simpson, A. M., Nassif, N. T., & McGowan, E. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0803-3 · Cited by 312
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
Bitting, R. L., & Armstrong, A. J. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0394 · Cited by 311
WWP2 is an E3 ubiquitin ligase for PTEN
Maddika, S., Kavela, S., Rani, N., Palicharla, V. R., Pokorny, J. L., Sarkaria, J. N., & Chen, J. (2011) · Nature Cell Biology · doi:10.1038/ncb2240 · Cited by 305
Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302
Salvesen, H. B., MacDonald, N., Ryan, A., Jacobs, I. J., Lynch, E. D., Akslen, L. A., & Das, S. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<22::aid-ijc1002>3.0.co;2-s · Cited by 294
Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer
Depowski, P. L., Rosenthal, S. I., & Ross, J. S. (2001) · Modern Pathology · doi:10.1038/modpathol.3880371 · Cited by 294
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
McConechy, M. K., Ding, J., Senz, J., Yang, W., Melnyk, N., Tone, A. A., Prentice, L. M., Wiegand, K. C., McAlpine, J. N., Shah, S. P., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.107 · Cited by 288
Valeri, N., Braconi, C., Gasparini, P., Murgia, C., Lampis, A., Paulus-Hock, V., Hart, J. R., Ueno, L., Grivennikov, S. I., Lovat, F., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.006 · Cited by 286
Risinger, J. I., Hayes, K., Maxwell, G. L., Carney, M. E., Dodge, R. K., Barrett, J. C., & Berchuck, A. (1998) · PubMed · Cited by 285
Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function
Papa, A., Wan, L., Bonora, M., Salmena, L., Song, M. S., Hobbs, R. M., Lunardi, A., Webster, K., Ng, C., Newton, R. H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.027 · Cited by 276
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
Rahdar, M., Inoue, T., Meyer, T., Zhang, J., Vazquez, F., & Devreotes, P. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811212106 · Cited by 266
Al-Khouri, A. M., Ma, Y., Togo, S. H., Williams, S., & Mustelin, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503045200 · Cited by 252
Suppression of PTEN Expression by NF-κB Prevents Apoptosis
Vasudevan, K. M., Gurumurthy, S., & Rangnekar, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1007-1021.2004 · Cited by 246
PTEN Level in Tumor Suppression: How Much Is Too Little?
Carracedo, A., Alimonti, A., & Pandolfi, P. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2488 · Cited by 246
Marsit, C. J., Zheng, S., Aldape, K., Hinds, P. W., Nelson, H. H., Wiencke, J. K., & Kelsey, K. T. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.006 · Cited by 243
Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray, I. C., Phillips, S. M. A., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., & Spurr, N. K. (1995) · PubMed · Cited by 232
Promoter Methylation and Silencing of PTEN in Gastric Carcinoma
Kang, Y.-H., Lee, H. S., & Kim, W. H. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780422 · Cited by 231
Okumura, K., Mendoza, M., Bachoo, R. M., DePinho, R. A., Cavenee, W. K., & Furnari, F. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605391200 · Cited by 224
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
García, J. M., Silva, J., Peña, C., Garcia, V., Rodríguez, R., Cruz, M. A., Cantos, B., Provencio, M., España, P., & Bonilla, F. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20062 · Cited by 224
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers
Salem, M. E., Weinberg, B. A., Xiu, J., El-Deiry, W. S., Hwang, J. J., Gatalica, Z., Philip, P. A., Shields, A. F., Lenz, H.-J., & Marshall, J. L. (2017) · Oncotarget · doi:10.18632/oncotarget.21169 · Cited by 216
Txnip balances metabolic and growth signaling via PTEN disulfide reduction
Hui, S. T. Y., Andres, A. M., Miller, A. K., Spann, N. J., Potter, D. W., Post, N. M., Chen, A. Z., Sachithanantham, S., Jung, D. Y., Kim, J. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800293105 · Cited by 214
Different mechanisms in the tumorigenesis of proximal and distal colon cancers
Lindblom, A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200101000-00013 · Cited by 212
Deubiquitylation and stabilization of PTEN by USP13
Zhang, J., Zhang, P., Wei, Y., Piao, H.-L., Wang, W., Maddika, S., Wang, M., Chen, D., Sun, Y., Hung, M.-C., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2874 · Cited by 209
Wu, Y., Song, Y., Xiong, Y., Wang, X., Xu, K., Han, B., Bai, Y., Li, L., Zhang, Y., & Zhou, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481648 · Cited by 208
Prostate cancer, PI3K, PTEN and prognosis
Wise, H. M., Hermida, M. A., & Leslie, N. R. (2017) · Clinical Science · doi:10.1042/cs20160026 · Cited by 206
Self-citationMighell, T. L., Evans-Dutson, S., & O’Roak, B. J. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.018 · Cited by 204
Rodríguez-Escudero, I., Oliver, M. D., Andrés-Pons, A., Molina, M., Cid, V. J., & Pulido, R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr337 · Cited by 198
Di Cristofano, A., & Ellenson, L. H. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091905 · Cited by 198
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis
Yuan, L., Lv, Y., Li, H., Gao, H., Song, S., Zhang, Y., Xing, G., Kong, X., Wang, L., Li, Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3218 · Cited by 197
Xu, L.-F., Wu, Z.-P., Chen, Y., Zhu, Q.-S., Hamidi, S., & Navab, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103698 · Cited by 194
Escrivà, M., Peiró, S., Herranz, N., Villagrasa, P., Dave, N., Montserrat-Sentís, B., Murray, S. A., Francí, C., Gridley, T., Virtanen, I., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02061-07 · Cited by 191
The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization
Fouladkou, F., Landry, T., Kawabe, H., Neeb, A., Lu, C., Brose, N., Stambolic, V., & Rotin, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803233105 · Cited by 188
Testa, U., Petrucci, E., Pasquini, L., Castelli, G., & Pelosi, E. (2018) · Medicines · doi:10.3390/medicines5010016 · Cited by 188
Fu, X., Tian, J., Zhang, L., Chen, Y., & Hao, Q. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.006 · Cited by 187
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions
Penna, E., Orso, F., & Taverna, D. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.479 · Cited by 186
Zhou, X.-P., Loukola, A., Salovaara, R., Nystrom-Lahti, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185
PTEN is destabilized by phosphorylation on Thr366
Maccario, H., Perera, N. M., Davidson, L., Downes, C. P., & Leslie, N. R. (2007) · Biochemical Journal · doi:10.1042/bj20061837 · Cited by 169
Self-citationLu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005577 · Cited by 168
PTEN Acetylation Modulates Its Interaction with PDZ Domain
Ikenoue, T., Inoki, K., Zhao, B., & Guan, K.-L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1107 · Cited by 168
Park, W. S., Do Heo, W., Whalen, J. H., O'Rourke, N. A., Bryan, H. M., Meyer, T., & Teruel, M. N. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.008 · Cited by 167
Ahmed, S. F., Deb, S., Paul, I., Chatterjee, A., Mandal, T., Chatterjee, U., & Ghosh, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321083 · Cited by 161
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
Wiencke, J. K., Zheng, S., Jelluma, N., Tihan, T., Vandenberg, S., Tamgüney, T., Baumber, R., Parsons, R., Lamborn, K. R., Berger, M. S., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-003 · Cited by 161
Wu, W., Yang, J., Feng, X., Wang, H., Ye, S., Yang, P., Tan, W., Wei, G., & Zhou, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-30 · Cited by 160
Themsche, C. V., Leblanc, V., Parent, S., & Asselin, É. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.009522 · Cited by 159
c-Jun promotes cellular survival by suppression of PTEN
Hettinger, K., Vikhanskaya, F., Poh, M. K., Lee, M. K., de Belle, I., Zhang, J.-T., Reddy, S. A. G., & Sabapathy, K. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401946 · Cited by 159
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han, S., Kato, H., Kato, S., Suzuki, T., Shibata, H., Ishii, S., Shiiba, K.-I., Matsuno, S., Kanamaru, R., & Ishioka, C. (2000) · PubMed · Cited by 158
PTEN mutations are common in sporadic microsatellite stable colorectal cancer
Nassif, N. T., Lobo, G. P., Wu, X., Henderson, C. J., Morrison, C. D., Eng, C., Jalaludin, B. B., & Segelov, E. (2004) · Oncogene · doi:10.1038/sj.onc.1207059 · Cited by 158
Non-genomic loss of PTEN function in cancer: not in my genes
Leslie, N. R., & Foti, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.005 · Cited by 158
Self-citationThe tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif
Walker, S. M., Leslie, N. R., Perera, N. M., Batty, I. H., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20031839 · Cited by 151
Self-citationLi, S., Shen, Y., Wang, M., Yang, J., Lv, M., Li, P., Chen, Z., & Jin, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16761 · Cited by 150
Brito, M. B., Goulielmaki, E., & Papakonstanti, E. A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00166 · Cited by 148
Gil, A., Andrés‐Pons, A., Fernández, E., Valiente, M., Torres, J., Cervera, J., & Pulido, R. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0380 · Cited by 146
Molecular Carcinogenesis of Endometrial Cancer
Liu, F.-S. (2007) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(08)60102-3 · Cited by 145
PTEN mutation, methylation and expression in breast cancer patients
Zhang, H., LIANG, F., Zhi-ling, J., Song, S., & Jiang, Z. (2013) · Oncology Letters · doi:10.3892/ol.2013.1331 · Cited by 142
Molecular footprints of human lung cancer progression
Yokota, J., & Kohno, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02203.x · Cited by 139
Sawai, H., Yasuda, A., Ochi, N., Ma, J., Matsuo, Y., Wakasugi, T., Takahashi, H., Funahashi, H., Sato, M., & Takeyama, H. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-56 · Cited by 135
Yang, L., Li, N., Wang, H., Jia, X., Wang, X., & Luo, J. (2012) · Oncology Reports · doi:10.3892/or.2012.1823 · Cited by 133
A Molecular Signature Predictive of Indolent Prostate Cancer
Irshad, S., Bansal, M., Castillo-Martín, M., Zheng, T., Aytés, À., Wenske, S., Magnen, C. L., Guarnieri, P., Sumazin, P., Benson, M. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006408 · Cited by 132
Berg, M., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Ågesen, T. H., Vatn, M. H., Mala, T., Sjo, O. H., Bakka, A. O., Moberg, I. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013978 · Cited by 129
Wu, Z., He, B., He, J., & Mao, X. (2012) · The Prostate · doi:10.1002/pros.22600 · Cited by 124
Pallarés, J., Bussaglia, E., Martínez‐Guitarte, J., Dolcet, X., Llobet‐Navàs, D., Rué, M., Sánchez‐Verde, L., Palacios, J., Prat, J., & Matías‐Guiu, X. (2004) · Modern Pathology · doi:10.1038/modpathol.3800347 · Cited by 122
Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype
Garcia, J. M., Silva, J. M., Domínguez, G., Gonzalez, R. M., Navarro, A., Carretero, L., Provencio, M., España, P., & Bonilla, F. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006273516976 · Cited by 122
The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
Snowdon, J., Zhang, X., Childs, T., Tron, V. A., & Feilotter, H. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022828 · Cited by 121
Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
Hanrahan, A. J., Schultz, N. D., Westfal, M. L., Sakr, R. A., Giri, D. D., Scarperi, S., Janikariman, M., Olvera, N., Stevens, E. V., She, Q., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0170 · Cited by 118
Tian, L., Fang, Y., Xue, J., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075885 · Cited by 117
Tibarewal, P., Zilidis, G., Spinelli, L., Schurch, N., Maccario, H., Gray, A., Perera, N. M., Davidson, L., Barton, G. J., & Leslie, N. R. (2012) · Science Signaling · doi:10.1126/scisignal.2002138 · Cited by 117
Self-citationMolecular pathogenesis of endometrial and ovarian cancer
Merritt, M. A., & Cramer, D. W. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0167 · Cited by 116
MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway
Ke, T., Wei, P., Yeh, K.-T., Chen, W. T., & Cheng, Y. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4305-2 · Cited by 116
PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription
Liang, H., Chen, X., Yin, Q., Ruan, D., Zhao, X., Zhang, C., McNutt, M. A., & Yin, Y. (2017) · Nature Communications · doi:10.1038/ncomms14771 · Cited by 116
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Serra, H., Chivite, Í., Angulo‐Urarte, A., Soler, A., Sutherland, J. D., Arruabarrena-Aristorena, A., Ragab, A., Lim, R., Malumbres, M., Fruttiger, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8935 · Cited by 114
miRNA profiling along tumour progression in ovarian carcinoma
Vaksman, O., Stavnes, H. T., Kærn, J., Trope, C. G., Davidson, B., & Reich, R. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01148.x · Cited by 111
Considerations When Analyzing the Methylation Status of PTEN Tumor Suppressor Gene
Zysman, M., Chapman, W. B., & Bapat, B. V. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64902-4 · Cited by 110
Li, J., Yang, S., Yan, W., Yang, J. W., Qin, Y., Lin, X., Xie, R., Wang, S., Jin, W. Y., Gao, F., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.76 · Cited by 108
Martins, F. C., de Santiago, I., Trinh, A. C., Xian, J., Guo, A., Sayal, K., Jimenez‐Liñan, M., Deen, S., Driver, K. E., Mack, M. L., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0526-8 · Cited by 108
Mutational Analysis of the PTEN Gene in Endometrial Carcinoma and Hyperplasia
Sun, H., Enomoto, T., Fujita, M., Wada, H., Yoshino, K., Ozaki, K., Nakamura, T., & Murata, Y. (2001) · American Journal of Clinical Pathology · doi:10.1309/7jx6-b9u9-3p0r-eqny · Cited by 104
Mahimainathan, L., & Choudhury, G. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314328200 · Cited by 103
Denning, G., Jean-Joseph, B., Prince, C. Z., Durden, D. L., & Vogt, P. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210175 · Cited by 102
The complexity of PTEN: mutation, marker and potential target for therapeutic intervention
Steelman, L. S., Bertrand, F. E., & McCubrey, J. A. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.537 · Cited by 102
Genetic Background Controls Tumor Development in Pten -Deficient Mice
Freeman, D., Lesche, R., Kertesz, N. L., Wang, S., Li, G., Gao, J., Groszer, M., Martinez-Diaz, H., Rozengurt, N., THOMAS, G. V., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4143 · Cited by 102
Li, N., Yang, L., Wang, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128886 · Cited by 101
The tumor suppressor PTEN interacts with p53 in hereditary cancer
NAKANISHI, A., Kitagishi, Y., Ogura, Y., & Matsuda, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2377 · Cited by 101
Yang, J.-M., Schiapparelli, P. V., Nguyen, H.-N., Igarashi, A., Zhang, Q., Abbadi, S., Amzel, L. M., Sesaki, H., Quiñones‐Hinojosa, A., & Iijima, M. (2017) · Oncogene · doi:10.1038/onc.2016.493 · Cited by 101
Lee, H.-J., Choi, H. J., Kang, C. S., Lee, H. J., Lee, W. S., & Park, C. S. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.111 · Cited by 96
Chae, H.-D., & Broxmeyer, H. E. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0465 · Cited by 93
CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression
Whelan, J. T., Forbes, S. L., & Bertrand, F. E. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3648 · Cited by 86
Kolasa, I. K., Rembiszewska, A., Janiec–Jankowska, A., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.007 · Cited by 84
Class I PI 3-kinases: Function and evolution
Kriplani, N., Hermida, M. A., Brown, E. R., & Leslie, N. R. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.05.002 · Cited by 83
Self-citationMund, T., & Pelham, H. R. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911714107 · Cited by 83
Ruano, Y., Ribalta, T., de Lope, Á. R., Campos‐Martín, Y., Fiaño, C., Pérez-Magán, E., Hernández-Moneo, J.-L., Mollejo, M., & Meléndez, B. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp64ybdvctirwv · Cited by 82
Kinases, tails and more: Regulation of PTEN function by phosphorylation
Fragoso, R., & Barata, J. T. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.015 · Cited by 79
Masson, G. R., Perišić, O., Burke, J. E., & Williams, R. L. (2015) · Biochemical Journal · doi:10.1042/bj20150931 · Cited by 78
Regulation of PTEN expression by noncoding RNAs
Li, W., Zhang, T., Guo, L., & Huang, L. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0898-9 · Cited by 78
Lima‐Fernandes, E., Enslen, H., Camand, E., Kotelevets, L., Boularan, C., Achour, L., Benmerah, A., Gibson, L. C. D., Baillie, G. S., Pitcher, J. A., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.178 · Cited by 77
Regulation of the tumor suppressor PTEN by SUMO
González, J., Campagna, M., Ortega-Molina, A., Marcos-Villar, L., de la Cruz-Herrera, C. F., González, D., Gallego, P. P. F., Lopitz‐Otsoa, F., Estéban, M., Rodríguez, M. S., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.135 · Cited by 74
SUN, H.-B., Chen, X., Ji, H. L., Wu, T., Lü, H., Zhang, Y., Li, H., & Li, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2665 · Cited by 74
Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma
Jang, K., Song, Y. S., Jang, S., Min, K., Na, W., Jang, S. M., Jun, Y. J., Lee, K. H., Choi, D., & Paik, S. S. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03468.x · Cited by 74
Naguib, A., Cooke, J. C., Happerfield, L. C., Kerr, L., Gay, L. J., Luben, R., Ball, R. Y., Mitrou, P. N., McTaggart, A., & Arends, M. J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-123 · Cited by 73
Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
Nip, H., Dar, A. A., Saini, S., Colden, M., Shahryari, V., Chowdhary, H., Yamamura, S., Mitsui, Y., Tanaka, Y., Kato, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12031 · Cited by 73
Li, C., Lyu, J., & Meng, Q. H. (2017) · Journal of Cancer · doi:10.7150/jca.17958 · Cited by 67
Allele-specific tumor spectrum in Pten knockin mice
Wang, H., Karikomi, M., Naidu, S. K., Rajmohan, R., Caserta, E., Chen, H., Rawahneh, M., Moffitt, J., Stephens, J. A., Fernández, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912524107 · Cited by 66
A Unified Nomenclature and Amino Acid Numbering for Human PTEN
Pulido, R., Baker, S. J., Barata, J. T., Carracedo, A., Cid, V. J., Chin-Sang, I. D., Davé, V., den Hertog, J., Devreotes, P. N., Eickholt, B. J., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005560 · Cited by 64
Self-citationInhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene
Tolkacheva, T., & Chan, A. M.-L. (2000) · Oncogene · doi:10.1038/sj.onc.1203331 · Cited by 64
Lang, Y., Xu, S., Ma, J., Wu, J., Jin, S., Cao, S., & Yu, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.084 · Cited by 62
PTEN: A yin-yang master regulator protein in health and disease
Pulido, R. (2015) · Methods · doi:10.1016/j.ymeth.2015.02.009 · Cited by 60
Gao, X., Yu, G. Y., Gong, H. F., Liu, L., Xu, Y., Hao, L. Q., Liu, P., Liu, Z. H., Bai, C. G., & Zhang, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-08413-z · Cited by 60
Maccario, H., Perera, N. M., Gray, A., Downes, C. P., & Leslie, N. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072280 · Cited by 58
Self-citationChu, P., Liang, A., Jiang, A., & Zong, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.8313 · Cited by 56
The ISG15-specific protease USP18 regulates stability of PTEN
Mustachio, L. M., Kawakami, M., Lu, Y., Rodriguez‐Canales, J., Mino, B., Behrens, C., Wistuba, I. I., Bota‐Rabassedas, N., Yu, J. Q., Lee, J. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13914 · Cited by 54
Lin, P.-L., Wu, D., Huang, C., He, T.-Y., Chou, M., Sheu, G., & Lee, H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu110 · Cited by 53
Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions
Leslie, N. R., Bennett, D., Alex, G. R. A. Y., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570427 · Cited by 53
Self-citationEnzymatic Analysis of PTEN Ubiquitylation by WWP2 and NEDD4-1 E3 Ligases
Chen, Z., Thomas, S. N., Bolduc, D. M., Jiang, X., Zhang, X., Wolberger, C., & Cole, P. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00448 · Cited by 48
Xiong, Y., Zhang, Y., Wu, Y., Wang, X., Wan, L., Li, L., & Zhou, L. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.04.017 · Cited by 47
AIF inhibits tumor metastasis by protecting PTEN from oxidation
Shen, S.-M., Guo, M., Xiong, Z., Yu, Y., Zhao, X., Zhang, F., & Chen, G. (2015) · EMBO Reports · doi:10.15252/embr.201540536 · Cited by 47
Yazdani, Y., Farazmandfar, T., Azadeh, H., & Zekavatian, Z. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0228-5 · Cited by 46
Uygur, B., Abramo, K., Leikina, E., Vary, C., Liaw, L., & Wu, W.-S. (2015) · The Prostate · doi:10.1002/pros.22974 · Cited by 45
Regulation of PTEN degradation and NEDD4–1 E3 ligase activity by Numb
Shao, C., Li, Z., Ahmad, N., & Liu, X. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1310351 · Cited by 45
miR-410–3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway
Zhang, Y., Zhang, D., Lv, J., Wang, S., & Zhang, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.176 · Cited by 43
Durrant, T. N., Hutchinson, J. L., Heesom, K. J., Anderson, K. E., Stephens, L., Hawkins, P. T., Marshall, A. J., Moore, S., & Hers, I. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017005173 · Cited by 41
Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases
Leslie, N. R., Dixon, M. J., Schenning, M., Gray, A., & Batty, I. H. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.010 · Cited by 39
Self-citationEpithelial ovarian cancer: Focus on genetics and animal models
Shan, W., & Liu, J. (2009) · Cell Cycle · doi:10.4161/cc.8.5.7848 · Cited by 39
Verrastro, I., Tveen‐Jensen, K., Woscholski, R., Spickett, C. M., & Pitt, A. R. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.004 · Cited by 39
Akyerli, C. B., Yüksel, Ş., Can, Ö., Erson-Omay, Z., Oktay, Y., Coşgun, E., Ülgen, E., Erdemgil, Y., Sav, A., von Deimling, A., et al. (2017) · Journal of neurosurgery · doi:10.3171/2016.11.jns16973 · Cited by 38
Jauhri, M., Bhatnagar, A., Gupta, S., Shokeen, Y., Minhas, S., & Aggarwal, S. (2016) · Medical Oncology · doi:10.1007/s12032-016-0820-2 · Cited by 32
The association of PTEN hypermethylation and breast cancer: a meta-analysis
Luo, S., Chen, J., & Mo, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s111684 · Cited by 32
Patil, C. G., Nuño, M., Elramsisy, A., Mukherjee, D. R., Carico, C., Dantis, J., Hu, J. L., Yu, J. S., Fan, X., Black, K. L., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos272 · Cited by 28
WWP2 and its association with PTEN in endometrial cancer
Clements, A., Bravo, V., Koivisto, C. S., Cohn, D. E., & Leone, G. W. (2015) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2015.05.004 · Cited by 27
Genomic Deletion at 10q23 in Prostate Cancer: More Than PTEN Loss?
Poluri, R. T. K., & Audet‐Walsh, É. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00246 · Cited by 27
MiR-200a acts as an oncogene in colorectal carcinoma by targeting PTEN
Li, Y., Sun, J., Cai, Y., Jiang, Y., Wang, X., Huang, X., Yin, Y., & Li, H. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.10.006 · Cited by 25
Bohn, B. A., Mina, S., Krohn, A., Simon, R., Kluth, M., Harasimowicz, S., Quaas, A., Bockhorn, M., Izbicki, J. R., Sauter, G., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.12.006 · Cited by 24
Ye, L., Wang, Y., Nie, L., Shen, Q., & Xu, M. (2017) · PubMed Central · Cited by 24
Ibeawuchi, C., Schmidt, H., Voß, R., Titze, U., Abbas, M., Neumann, J., Eltze, E., Hoogland, A. M., Jenster, G. W., Brandt, B., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023856 · Cited by 20
Cited by
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Alzahrani, A. S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.009 · Cited by 1,054
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Yu, L., Wei, J., & Liu, P. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.019 · Cited by 763
The role of collagen in cancer: from bench to bedside
Xu, S., Xu, H., Wang, W., Li, S., Li, H., Li, T., Zhang, W., Yu, X., & Liu, L. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2058-1 · Cited by 735
Metadata
- Authors
- Álvarez-Garcia, V., Tawil, Y., Wise, H. M., & Leslie, N. R.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 59
- Pages
- 66-79
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2911631458
- Cited by
- 401
- References
- 204
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.